Skip to content

A trial of intraoperative 5-fluorouracil (5-FU) in primary glaucoma surgery: effects on long term intraocular pressure control and disease progression

A trial of intraoperative 5-fluorouracil (5-FU) in primary glaucoma surgery: effects on long term intraocular pressure control and disease progression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN81872640
Enrollment
367
Registered
2000-10-24
Start date
1995-09-01
Completion date
Unknown
Last updated
2018-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma Eye Diseases Glaucoma

Interventions

5-FU versus placebo

Sponsors

Medical Research Council (MRC) (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are deemed to have inadequate intraocular pressure control in one or both eyes with or without medical treatment, who are listed for glaucoma filtration surgery by their consultant

Exclusion criteria

Exclusion criteria: 1. Anterior segment percutaneous versus aphakia 2. Previous glaucoma filtration surgery 3. Uveitis 4. Any previous intraocular surgery

Design outcomes

Secondary

MeasureTime frame
Changes in visual fields and optic disc cupping

Primary

MeasureTime frame
Levels of intraocular pressure following surgery

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026